The global in situ hybridization market size is projected to reach USD 1.3 billion by 2025 from USD 0.9 billion in 2020, at a CAGR of 7.4% during the forecast period. Increasing awareness of companion diagnostics and the growing incidence of cancer and genetic disorders are the major factors driving the growth of this market.
The prominent players operating in the ISH market are Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (US), Agilent Technologies (US), ThermoFisher Scientific (US)
To know about the assumptions considered for the study download the pdf brochure
Abbott Laboratories (US) has the largest market share in the ISH market. The company has gained its leadership through its VYSIS FISH platform and provides products and software for different types of cancer and prenatal and postnatal diagnosis. The company focuses on launching technologically advanced and innovative products in the market, such as kits, reagents, buffers, probes, and accessories. With its wide product portfolio, constant focus on R&D activities, and strategic collaborations, the company has created a strong foothold in the ISH market. The company has a strong presence in North America and the APAC and distribution networks and subsidiaries
Roche (Switzerland) is a world leader in IVD and tissue-based cancer diagnostics. The company has revolutionized cancer diagnostics across the globe through its cutting-edge testing automation. The company’s portfolio of more than 250 cancer tests and associated instruments makes it the leading global supplier of cancer diagnostic systems to the pathology market. The company’s new launches were focused mainly on cancer diagnostics. Its recent collaborations demonstrate a focus on expanding its diagnostic business and increasing accessibility for customers. Roche has shown a focus on differentiating its products in this market—as evident from the company’s emphasis on product innovation. It has launched innovative products over the last three years. For example, in 2019, the company introduced the VENTANA HER2 Dual ISH companion diagnostic test.
In situ Hybridization (ISH) Market by Product (Consumables (Kits, Probes) Software), Technology (FISH (DNA, RNA), CISH), Application (Cancer, Infectious Disease), and End User (Diagnostic Labs, Research Institutes, CROs), Region - Global Forecast to 2025
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE